title: Cellular and mediator profile in bronchoalveolar lavage of guinea pigs after toluene diisocyanate (TDI) exposure.
abstract: Toluene diisocyanate (TDI) is a volatile, highly reactive chemical widely used as a polymerizing agent in the production of polyurethane foams, lacquers, adhesives, and other items. Repeated airway exposures in the workplace to TDI may cause a concentration-dependent risk of developing chronic airway disorders. Different pathomechanisms are involved. IgE-mediated sensitization and irritative effects were clearly demonstrated in exposed subjects as well as in animals. In this study we examined the cellular and mediator composition in bronchoalveolar lavage fluid (BALF) of guinea pigs (eight in each group) exposed to TDI (10, 20, or 30 ppb) on 5 consecutive days for 2 hours each. Increased numbers of eosinophils and significantly elevated levels of LTB4 and LTC4/LTD4/LTE4 were obtained in BALF of all exposed animals when compared to nonexposed control animals. PGD2 and TXB2 remained unaltered in BALF. Stimulation of BALF cells of exposed and control animals with Ca-ionophore A23187 and arachidonic acid induced an increased generation of LTB4. Furthermore, BALF cells of the exposed animal groups generated immunoreactive LTC4/LTD4/LTE4, whereas controls did not show peptido-leukotriene formation in the presence and absence of stimuli. Our data clearly demonstrate an influx of eosinophils into the airways associated with mediator release and higher cellular responsiveness after TDI exposure.
authors.affiliation: Professional Associations' Research Institute for Occupational Medicine (BGFA), Ruhr-University Bochum, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Raulf
authors.forename: L
authors.initials: L
authors.lastname: Tennie
authors.forename: B
authors.initials: B
authors.lastname: Marczynski
authors.forename: J
authors.initials: J
authors.lastname: Potthast
authors.forename: W
authors.initials: W
authors.lastname: Marek
authors.forename: X
authors.initials: X
authors.lastname: Baur
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D001249:Asthma / Q000139:chemically induced* / Q000276:immunology; D016535:Bronchial Hyperreactivity / Q000139:chemically induced / Q000276:immunology; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology*; D000001:Calcimycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004804:Eosinophils / Q000187:drug effects / Q000276:immunology; D005260:Female; D006168:Guinea Pigs; D018836:Inflammation Mediators / Q000378:metabolism*; D007958:Leukocyte Count / Q000187:drug effects; D015289:Leukotrienes / Q000378:metabolism; D015230:Prostaglandin D2 / Q000378:metabolism; D013929:Thromboxane B2 / Q000378:metabolism; D014051:Toluene 2,4-Diisocyanate / Q000633:toxicity*
chemical_list: D018836:Inflammation Mediators; D015289:Leukotrienes; D014051:Toluene 2,4-Diisocyanate; D016718:Arachidonic Acid; D000001:Calcimycin; D013929:Thromboxane B2; D015230:Prostaglandin D2